_1777294237270_124456903.png&w=64&q=75){kind=small}
AI Aims to Clarify Antidepressant Use
The article focused on the use of artificial intelligence to improve depression treatment, where clinical trials have shown that applying AI-based tools reduces the likelihood of patients discontinuing antidepressants by 38% during the first eight weeks compared to traditional care. Techniques combining artificial intelligence with genetic data and brain imaging have been developed to identify biological patterns of depression, helping to select the most suitable medication from the outset and minimizing the trial-and-error process with ineffective drugs. The results indicate that these technologies may accelerate the treatment process and reduce suffering durations, but they are still under research and should not be used without medical supervision. Current trials involve more than 2,000 patients in the United States and India.
Notice: This Is an AI-Generated Summary
Comments (0)